ARCHIVES

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

This article is from The Cancer Letter archive.

Vol. 15 No. 10 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles

November 4, 1983